Riskpilot← Back to searchSign inGet full accessLJ Läkarkonsult AB
ABActiveOrg 5593349284Torsgatan 12Hospital activities · NACE 8610Est. 20210 employees
Revenue 2025
SEK 119K
EBITDA margin
78.2%
-26% vs 2024
Equity ratio
67.1%
Financial strength
Net profit 2025
SEK 71K
-30% vs 2024
| Revenue | SEK 119K | — |
| EBITDA | SEK 93K | -26% |
| Net profit | SEK 71K | -30% |
| Total assets | SEK 143K | -23% |
| Equity | SEK 96K | -24% |
| Employees | 0 | — |
Legal name
LJ Läkarkonsult AB
Org number
5593349284
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
14 september 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Medicinsk och kirurgisk läkarkonsultverksamhet.
Address
Torsgatan 12
Email
jhrekstrand@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 110 | 198 | 0 | 0 | 119 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 89 | 159 | 172 | 125 | 93 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 89 | 159 | 172 | 125 | 93 |
| Net financials | — | — | — | — | — |
| Profit before tax | 89 | 160 | 172 | 125 | 92 |
| Tax | −18 | −33 | −34 | −24 | −21 |
| Net profit | 71 | 127 | 138 | 101 | 71 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 141 | 240 | 269 | 186 | 143 |
| Equity | 96 | 152 | 163 | 126 | 96 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 45 | 89 | 106 | 60 | 47 |
| Total debt | 45 | 89 | 106 | 60 | 47 |
EBITDA margin
78.2%
This company
15.8%
Market median
+395% vs market
20212025
Equity ratio
67.1%
This company
38.2%
Market median
+76% vs market
20212025
Return on equity
74.0%
This company
18.4%
Market median
+302% vs market
20212025
Net profit margin
59.7%
This company
8.1%
Market median
+637% vs market
20212025
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
20212025
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-09-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LJ Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Louise Eva Berglund Ekstrand | Deputy Board Member | 0 companies |
| Johan Henrik Roger Ekstrand | Board of Directors | 0 companies |